These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1936624)

  • 1. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
    Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB
    Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of arginine-induced glucagon release by epinephrine and glucose levels in man.
    Beard JC; Weinberg C; Pfeifer MA; Best JD; Halter JB; Porte D
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1271-7. PubMed ID: 6841561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation of B and A cell function during prolonged glucose infusion in human subjects.
    Ward WK; Halter JB; Beard JC; Porte D
    Am J Physiol; 1984 May; 246(5 Pt 1):E405-11. PubMed ID: 6372519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of epinephrine on islet hormone secretion in the dog.
    Ahrén B; Veith RC; Taborsky GJ
    Int J Pancreatol; 1988 Jul; 3(5):375-88. PubMed ID: 2902147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-adrenergic blockade improves glucose-potentiated insulin secretion in non-insulin-dependent diabetes mellitus.
    Broadstone VL; Pfeifer MA; Bajaj V; Stagner JI; Samols E
    Diabetes; 1987 Aug; 36(8):932-7. PubMed ID: 2885238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
    Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ
    J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
    Ahrén B; Larsson H; Holst JJ
    J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
    Banarer S; McGregor VP; Cryer PE
    Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of insulin secretion in diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Porte D
    Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
    Hollander PM; Asplin CM; Palmer JP
    Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Røder ME; Porte D; Schwartz RS; Kahn SE
    J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose intolerance in thyrotoxic rats: role of insulin, glucagon, and epinephrine.
    Ikeda T; Mokuda O; Tominaga M; Mashiba H
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E843-9. PubMed ID: 3059820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of added fat on plasma glucose and insulin response to ingested potato in individuals with NIDDM.
    Gannon MC; Ercan N; Westphal SA; Nuttall FQ
    Diabetes Care; 1993 Jun; 16(6):874-80. PubMed ID: 8325201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients.
    Johnston C; Ward WK; Beard JC; McKnight B; Porte D
    Diabet Med; 1990 Feb; 7(2):119-25. PubMed ID: 2137751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.